Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04543110
Title Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC (RADIANT)
Acronym RADIANT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ottawa Hospital Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.